Explore
Second Generation Patents in Pharmaceutical Innovation
Hyewon Ahn
2014
0 Ungluers have
Faved this Work
Login to Fave
The development of new medications and improvements thereof are crucial to ensure continued gains in health. The development process is long and costly, and mainly to produce the information to meet high regulatory requirements. In contrast, imitation involves negligible costs and much reduced risks. This is one of the reasons the pharmaceutical industry depends greatly on patent protection. Despite the existing patent system, however, the number of new medications per year has decreased, especially during the last decade. In comparison, the number of second generation patents and products has been drastically increased. This industry is accused both of neglecting its real mission of providing new medications while generating second generation products, and of preventing the entry of generics. The dissertation reviewed whether the concerns are justified, and, if so, whether or how the patent system can improve the situation that confronts pharmaceutical companies and society.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 54 times via unglue.it ebook links.
- 54 - pdf (CC BY) at Unglue.it.
Keywords
- Gewerblicher Rechtsschutz
- Gewerblicher Rechtsschutz, Urheberrecht / Gewerblicher Rechtsschutz und Medienrecht, Markenrecht
- Markenrecht
- Urheberrecht / Gewerblicher Rechtsschutz und Medienrecht
Links
DOI: 10.5771/9783845250861Editions